Plasticity of invariant NKT cell regulation of allergic airway disease is dependent on IFN-γ production

Hiroyuki Matsuda, Katsuyuki Takeda, Toshiyuki Koya, Masakazu Okamoto, Yoshiki Shiraishi, Nobuaki Miyahara, Azzeddine Dakhama, Jennifer L. Matsuda, Laurent Gapin, Erwin W. Gelfand

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Invariant NKT cells (iNKT cells) play a pivotal role in the development of allergen-induced airway hyperresponsiveness (AHR) and inflammation. However, it is unclear what role they play in the initiation (sensitization) phase as opposed to the effector (challenge) phase. The role of iNKT cells during sensitization was examined by determining the response of mice to intratracheal transfer of OVA-pulsed or OVA-α-galactosylceramide (OVA/αGalCer)- pulsed bone marrow-derived dendritic cells (BMDCs) prior to allergen challenge. Wild-type (WT) recipients of OVA-BMDCs developed AHR, increased airway eosinophilia, and increased levels of Th2 cytokines in bronchoalveolar lavage fluid, whereas recipients of OVA/αGalCer BMDCs failed to do so. In contrast, transfer of these same OVA/αGalCer BMDCs into IFN-γ-deficient (IFN-γ-/-) mice enhanced the development of these lung allergic responses, which was reversed by exogenous IFN-γ treatment following OVA-BMDC transfer. Further, Jα18-deficient recipients, which lack iNKT cells, developed the full spectrum of lung allergic responses following reconstitution with highly purified WT liver or spleen iNKT cells and transfer of OVA-BMDCs, whereas reconstituted recipients of OVA/αGalCer BMDCs failed to do so. Transfer of iNKT cells from IFN-γ-/- mice restored the development of these responses in Jα18-deficient recipients following OVA-BMDC transfer; the responses were enhanced following OVA/αGalCer BMDC transfer. iNKT cells from these IFN-γ-/- mice produced higher levels of IL-13 in vitro compared with WT iNKT cells. These data identify IFN-γ as playing a critical role in dictating the consequences of iNKT cell activation in the initiation phase of the development of AHR and airway inflammation.

Original languageEnglish
Pages (from-to)253-262
Number of pages10
JournalJournal of Immunology
Volume185
Issue number1
DOIs
Publication statusPublished - Jul 1 2010
Externally publishedYes

Fingerprint

Natural Killer T-Cells
Dendritic Cells
Galactosylceramides
Bone Marrow
Allergens
Inflammation
Lung
Interleukin-13
Bronchoalveolar Lavage Fluid
Eosinophilia
Spleen
Cytokines
Liver

ASJC Scopus subject areas

  • Immunology
  • Medicine(all)

Cite this

Plasticity of invariant NKT cell regulation of allergic airway disease is dependent on IFN-γ production. / Matsuda, Hiroyuki; Takeda, Katsuyuki; Koya, Toshiyuki; Okamoto, Masakazu; Shiraishi, Yoshiki; Miyahara, Nobuaki; Dakhama, Azzeddine; Matsuda, Jennifer L.; Gapin, Laurent; Gelfand, Erwin W.

In: Journal of Immunology, Vol. 185, No. 1, 01.07.2010, p. 253-262.

Research output: Contribution to journalArticle

Matsuda, H, Takeda, K, Koya, T, Okamoto, M, Shiraishi, Y, Miyahara, N, Dakhama, A, Matsuda, JL, Gapin, L & Gelfand, EW 2010, 'Plasticity of invariant NKT cell regulation of allergic airway disease is dependent on IFN-γ production', Journal of Immunology, vol. 185, no. 1, pp. 253-262. https://doi.org/10.4049/jimmunol.0902301
Matsuda, Hiroyuki ; Takeda, Katsuyuki ; Koya, Toshiyuki ; Okamoto, Masakazu ; Shiraishi, Yoshiki ; Miyahara, Nobuaki ; Dakhama, Azzeddine ; Matsuda, Jennifer L. ; Gapin, Laurent ; Gelfand, Erwin W. / Plasticity of invariant NKT cell regulation of allergic airway disease is dependent on IFN-γ production. In: Journal of Immunology. 2010 ; Vol. 185, No. 1. pp. 253-262.
@article{03b9b702b89c4c92bf0967f461b21fb3,
title = "Plasticity of invariant NKT cell regulation of allergic airway disease is dependent on IFN-γ production",
abstract = "Invariant NKT cells (iNKT cells) play a pivotal role in the development of allergen-induced airway hyperresponsiveness (AHR) and inflammation. However, it is unclear what role they play in the initiation (sensitization) phase as opposed to the effector (challenge) phase. The role of iNKT cells during sensitization was examined by determining the response of mice to intratracheal transfer of OVA-pulsed or OVA-α-galactosylceramide (OVA/αGalCer)- pulsed bone marrow-derived dendritic cells (BMDCs) prior to allergen challenge. Wild-type (WT) recipients of OVA-BMDCs developed AHR, increased airway eosinophilia, and increased levels of Th2 cytokines in bronchoalveolar lavage fluid, whereas recipients of OVA/αGalCer BMDCs failed to do so. In contrast, transfer of these same OVA/αGalCer BMDCs into IFN-γ-deficient (IFN-γ-/-) mice enhanced the development of these lung allergic responses, which was reversed by exogenous IFN-γ treatment following OVA-BMDC transfer. Further, Jα18-deficient recipients, which lack iNKT cells, developed the full spectrum of lung allergic responses following reconstitution with highly purified WT liver or spleen iNKT cells and transfer of OVA-BMDCs, whereas reconstituted recipients of OVA/αGalCer BMDCs failed to do so. Transfer of iNKT cells from IFN-γ-/- mice restored the development of these responses in Jα18-deficient recipients following OVA-BMDC transfer; the responses were enhanced following OVA/αGalCer BMDC transfer. iNKT cells from these IFN-γ-/- mice produced higher levels of IL-13 in vitro compared with WT iNKT cells. These data identify IFN-γ as playing a critical role in dictating the consequences of iNKT cell activation in the initiation phase of the development of AHR and airway inflammation.",
author = "Hiroyuki Matsuda and Katsuyuki Takeda and Toshiyuki Koya and Masakazu Okamoto and Yoshiki Shiraishi and Nobuaki Miyahara and Azzeddine Dakhama and Matsuda, {Jennifer L.} and Laurent Gapin and Gelfand, {Erwin W.}",
year = "2010",
month = "7",
day = "1",
doi = "10.4049/jimmunol.0902301",
language = "English",
volume = "185",
pages = "253--262",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "1",

}

TY - JOUR

T1 - Plasticity of invariant NKT cell regulation of allergic airway disease is dependent on IFN-γ production

AU - Matsuda, Hiroyuki

AU - Takeda, Katsuyuki

AU - Koya, Toshiyuki

AU - Okamoto, Masakazu

AU - Shiraishi, Yoshiki

AU - Miyahara, Nobuaki

AU - Dakhama, Azzeddine

AU - Matsuda, Jennifer L.

AU - Gapin, Laurent

AU - Gelfand, Erwin W.

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Invariant NKT cells (iNKT cells) play a pivotal role in the development of allergen-induced airway hyperresponsiveness (AHR) and inflammation. However, it is unclear what role they play in the initiation (sensitization) phase as opposed to the effector (challenge) phase. The role of iNKT cells during sensitization was examined by determining the response of mice to intratracheal transfer of OVA-pulsed or OVA-α-galactosylceramide (OVA/αGalCer)- pulsed bone marrow-derived dendritic cells (BMDCs) prior to allergen challenge. Wild-type (WT) recipients of OVA-BMDCs developed AHR, increased airway eosinophilia, and increased levels of Th2 cytokines in bronchoalveolar lavage fluid, whereas recipients of OVA/αGalCer BMDCs failed to do so. In contrast, transfer of these same OVA/αGalCer BMDCs into IFN-γ-deficient (IFN-γ-/-) mice enhanced the development of these lung allergic responses, which was reversed by exogenous IFN-γ treatment following OVA-BMDC transfer. Further, Jα18-deficient recipients, which lack iNKT cells, developed the full spectrum of lung allergic responses following reconstitution with highly purified WT liver or spleen iNKT cells and transfer of OVA-BMDCs, whereas reconstituted recipients of OVA/αGalCer BMDCs failed to do so. Transfer of iNKT cells from IFN-γ-/- mice restored the development of these responses in Jα18-deficient recipients following OVA-BMDC transfer; the responses were enhanced following OVA/αGalCer BMDC transfer. iNKT cells from these IFN-γ-/- mice produced higher levels of IL-13 in vitro compared with WT iNKT cells. These data identify IFN-γ as playing a critical role in dictating the consequences of iNKT cell activation in the initiation phase of the development of AHR and airway inflammation.

AB - Invariant NKT cells (iNKT cells) play a pivotal role in the development of allergen-induced airway hyperresponsiveness (AHR) and inflammation. However, it is unclear what role they play in the initiation (sensitization) phase as opposed to the effector (challenge) phase. The role of iNKT cells during sensitization was examined by determining the response of mice to intratracheal transfer of OVA-pulsed or OVA-α-galactosylceramide (OVA/αGalCer)- pulsed bone marrow-derived dendritic cells (BMDCs) prior to allergen challenge. Wild-type (WT) recipients of OVA-BMDCs developed AHR, increased airway eosinophilia, and increased levels of Th2 cytokines in bronchoalveolar lavage fluid, whereas recipients of OVA/αGalCer BMDCs failed to do so. In contrast, transfer of these same OVA/αGalCer BMDCs into IFN-γ-deficient (IFN-γ-/-) mice enhanced the development of these lung allergic responses, which was reversed by exogenous IFN-γ treatment following OVA-BMDC transfer. Further, Jα18-deficient recipients, which lack iNKT cells, developed the full spectrum of lung allergic responses following reconstitution with highly purified WT liver or spleen iNKT cells and transfer of OVA-BMDCs, whereas reconstituted recipients of OVA/αGalCer BMDCs failed to do so. Transfer of iNKT cells from IFN-γ-/- mice restored the development of these responses in Jα18-deficient recipients following OVA-BMDC transfer; the responses were enhanced following OVA/αGalCer BMDC transfer. iNKT cells from these IFN-γ-/- mice produced higher levels of IL-13 in vitro compared with WT iNKT cells. These data identify IFN-γ as playing a critical role in dictating the consequences of iNKT cell activation in the initiation phase of the development of AHR and airway inflammation.

UR - http://www.scopus.com/inward/record.url?scp=77956219087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956219087&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.0902301

DO - 10.4049/jimmunol.0902301

M3 - Article

VL - 185

SP - 253

EP - 262

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 1

ER -